Immune Response Against Hepatitis B Virus Induced by HBsAg Recombinant Adenovirus-Transduced Dendritic Cells in BALB/c Mice

HUANG Yin,CHEN Zhi,JIA Hong-yu,WU Wei,CAI Ling-fei,ZHOU Cheng
DOI: https://doi.org/10.3760/j:issn:0254-5101.2006.06.019
2006-01-01
Abstract:Objective To study the immune response against hepatitis B virus induced by HBsAg recombinant adenovirus-transduced dendritic cells (DC) in vivo and in vitro. Methods DC were isolated from bone marrow cells of BALB/c mice, transfected with HBsAg recombinant adenovirus Ad-S (DC/Ad-S) or pulsed with HBsAg (DC/HBsAg) and used for analysis of the phenotypic markers by flow cytometry and the stimulatory capacity in mixed leukocyte reaction (MLR) . HBsAg-specific activity of splenic cytotoxic T lymphocyte (CTL) of BALB/c mice was measured by LDH release assay and the anti-HBs titers in sera was examined by RIA after being immunized with DC/Ad-S (12), DC/HBsAg (12) or pcDNA3.1(+)-S plsmid(8). Intracellular cytokines of proliferative T cells in autologous MLR or of splenic T cells after immunization was detected by flow cytometry. Results Either the Ad-S- or Ad-lacZ-transduced DC or HBsAg-pulsed DC or untreated DC expressed similar levels of phenotypic markers, and showed similar stimulatory capacity in either allogeneic or autologous MLR. DC/Ad-S and DC/HBsAg induced more TH or Tc secreting IFN-γrather than IL-4 in autologous MLR. DC/Ad-S more efficiently stimulated splenic TH to secrete IFN-γthan pcDNA3.1( + )-S (P0.05) and splenic Tc to product IFN-γthan DC/HBsAg (P0.01) and plasmid DNA (P 0.01), and induced stronger splenic HBsAg-specific CTL responses than that induced by DC/HBsAg. However, DC/Ad-S and DC/HBsAg primed splenic Tc to secret IFN-γand splenic HBsAg-specific CTL, more reductively than plasmid DNA at 4 weeks after immunization. Anti-HBs response elicited by DC vaccination was much weaker than that induced by pcDNA3.1( + )-S at either 2 or 4 weeks after immunization. Conclusion HBsAg recombinant adenovirus-transduced DC can induce more enhanced TH1/ Tcl (typeⅠ) cell-mediated immunity and HBsAg-specific CTL than HBsAg-pulsed DC or plasmid DNA, and may be an efficient inducer in priming HBV-specific T cell response.
What problem does this paper attempt to address?